BACKGROUND
Measuring non-invasive exhaled biomarkers of inflammation may be important in monitoring asthma therapy.
OBJECTIVE
Evaluate exhaled nitric oxide with add-on leukotriene synthesis inhibitor in moderate-severe persistent asthmatics on combination controllers.
METHODS
In a non-randomized,